Versant Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $634K | Sell |
9,067
-229
| -2% | -$16K | 0.1% | 130 |
|
|
2025
Q1 | $683K | Buy |
9,296
+8,562
| +1,166% | +$629K | 0.11% | 109 |
|
|
2024
Q4 | $48.1K | Buy |
734
+707
| +2,619% | +$46.3K | 0.01% | 593 |
|
|
2024
Q3 | $2.1K | Sell |
27
-436
| -94% | -$34K | ﹤0.01% | 1551 |
|
|
2024
Q2 | $36.1K | Buy |
463
+436
| +1,615% | +$34K | 0.01% | 502 |
|
|
2024
Q1 | $1.83K | Hold |
27
| – | – | ﹤0.01% | 1382 |
|
|
2023
Q4 | $1.82K | Sell |
27
-94
| -78% | -$6.33K | ﹤0.01% | 1317 |
|
|
2023
Q3 | $8.19K | Buy |
121
+6
| +5% | +$406 | ﹤0.01% | 799 |
|
|
2023
Q2 | $8.23K | Hold |
115
| – | – | ﹤0.01% | 848 |
|
|
2023
Q1 | $7.98K | Buy |
115
+94
| +448% | +$6.52K | ﹤0.01% | 782 |
|
|
2022
Q4 | $1.42K | Hold |
21
| – | – | ﹤0.01% | 1223 |
|
|
2022
Q3 | $1K | Hold |
21
| – | – | ﹤0.01% | 1184 |
|
|
2022
Q2 | $1K | Hold |
21
| – | – | ﹤0.01% | 1203 |
|
|
2022
Q1 | $1K | Hold |
21
| – | – | ﹤0.01% | 1231 |
|
|
2021
Q4 | $1K | Sell |
21
-4
| -16% | -$190 | ﹤0.01% | 1226 |
|
|
2021
Q3 | $2K | Buy |
+25
| New | +$2K | ﹤0.01% | 1098 |
|
|
2018
Q1 | – | Sell |
-565
| Closed | -$19K | – | 1482 |
|
|
2017
Q4 | $19K | Buy |
+565
| New | +$19K | 0.01% | 672 |
|